ImageneBio Q2 EPS $(0.63) Beats $(1.05) Estimate

Benzinga · 2d ago
ImageneBio (NASDAQ:IMA) reported quarterly losses of $(0.63) per share which beat the analyst consensus estimate of $(1.05) by 40 percent.